Advertisement

Cancer Causes & Control

, Volume 18, Issue 1, pp 29–39 | Cite as

Serum organochlorines and breast cancer: a case–control study among African-American women

  • Nicole M. Gatto
  • Matthew P. Longnecker
  • Michael F. Press
  • Jane Sullivan-Halley
  • Roberta McKean-Cowdin
  • Leslie Bernstein
OriginalPaper

Abstract

This population-based case–control study of African-American women (355 breast cancer case patients, 327 controls) examined the association between breast cancer and circulating levels of PCBs and dichlorodiphenyldichloroethene (DDE), a metabolite of DDT. Case patients were diagnosed with invasive breast carcinoma and interviewed between June 1995 and July 1998, and control subjects were identified by random digit dialing methods. Serum levels of DDE and total PCBs were adjusted for total lipid content. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated using multivariable unconditional logistic regression methods. Effect modification by tumor receptor status and cancer treatment was investigated. Breast cancer risk was not associated with increasing quintiles of lipid-adjusted PCBs or DDE (highest versus lowest quintile adjusted for age, body mass index (BMI) and breastfeeding for DDE: OR = 1.02, 95% CI = (0.61, 1.72), p-trend = 0.74; for PCBs: OR = 1.01, 95% CI = (0.63, 1.63), p-trend = 0.56). Risk did not differ by strata of BMI, breastfeeding, parity, menopausal status or tumor receptor status. This study, the largest study of African-American women to date, does not support a role of DDE and total PCBs in breast cancer risk at the levels measured.

Keywords

Organochlorines Breast cancer African-Americans DDT DDE PCBs Pesticides Cancer Women 

Notes

Acknowledgments

This study was supported by the National Institute of Child Health and Human Development, with additional support from the National Cancer Institute (NCI), through a contract with the University of Southern California University of Southern California (N01 HD 3–3175), by a grant from the National Institute of Environmental Health Sciences (NIEHS), ES07084, and in part by the Intramural Research Program of the National Institutes of Health, NIEHS. General support from NCI through the SEER Program contract to the Cancer Surveillance Program for Los Angeles County (N01-CN-67010) is also acknowledged. The collection of cancer incidence data for Los Angeles County used in this publication was also supported by the California Department of Health Services as part of the statewide cancer reporting program mandated by the California Health and Safety Code Section 103885. The ideas and opinions expressed herein are those of the authors, and no endorsement by the State of California, Department of Health Services, is intended or should be inferred.

References

  1. 1.
    SEER. (www.seer.cancer.gov) SEER*Stat Database: Incidence – SEER 9 Regs Public-Use, Nov 2004 Sub (1973–2002), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2005, based on the November 2004 submissionGoogle Scholar
  2. 2.
    IARC (1999) Hormonal contraception and postmenopausal hormonal therapy. IARC monographs on the evaluation of carcinogenic risks to humans, LyonGoogle Scholar
  3. 3.
    Brinton LA, Brogan DR, Coates RJ, Swanson CA, Potischman N, Stanford JL (1998) Breast cancer risk among women under 55 years of age by joint effects of usage of oral contraceptives and hormone replacement therapy. Menopause 5(3):145–151PubMedGoogle Scholar
  4. 4.
    Butler, LM, Potischman, NA, Newman, B,  et al. 2000Menstrual risk factors and early-onset breast cancerCancer Causes Control11451458PubMedCrossRefGoogle Scholar
  5. 5.
    Adami HO, Lipworth L, Titus-Ernstoff L, et al (1995) Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6(6):551–566PubMedCrossRefGoogle Scholar
  6. 6.
    Longnecker MP, Rogan WJ, Lucier G (1997) The human health effects of DDT (dichlorodiphenyltrichloroethane) and PCBS (polychlorinated biphenyls) and an overview of organochlorines in public health. Annu Rev Public Health 18:211–244PubMedCrossRefGoogle Scholar
  7. 7.
    Ahlborg UG, Lipworth L, Titus-Ernstoff L, et al (1995) Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25(6):463–531PubMedGoogle Scholar
  8. 8.
    Dich J, Zahm SH, Hanberg A, Adami HO (1997) Pesticides and cancer. Cancer Causes Control 8(3):420–443PubMedCrossRefGoogle Scholar
  9. 9.
    Kimbrough RD, Krouskas CA (2003) Human exposure to polychlorinated biphenyls and health effects: a critical synopsis. Toxicol Rev 22(4):217–233PubMedCrossRefGoogle Scholar
  10. 10.
    Unger M, Kiaer H, Blichert-Toft M, Olsen J, Clausen J (1984) Organochlorine compounds in human breast fat from deceased with and without breast cancer and in a biopsy material from newly diagnosed patients undergoing breast surgery. Environ Res 34(1):24–28PubMedCrossRefGoogle Scholar
  11. 11.
    Falck F, Jr, Ricci A, Jr, Wolff MS, Godbold J, Deckers P (1992) Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47(2):143–146PubMedGoogle Scholar
  12. 12.
    Wassermann M, Nogueira DP, Tomatis L, et al (1976) Organochlorine compounds in neoplastic and adjacent apparently normal breast tissue. Bull Environ Contam Toxicol 15(4):478–484PubMedCrossRefGoogle Scholar
  13. 13.
    Mussalo-Rauhamaa H, Hasanen E, Pyysalo H, Antervo K, Kauppila R, Pantzar P (1990) Occurrence of beta-hexachlorocyclohexane in breast cancer patients. Cancer 66(10):2124–2128PubMedCrossRefGoogle Scholar
  14. 14.
    Dewailly E, Dodin S, Verreault R, et al (1994) High organochlorine body burden in women with estrogen receptor-positive breast cancer. J Natl Cancer Inst 86(3):232–234PubMedGoogle Scholar
  15. 15.
    Aronson KJ, Miller AB, Woolcott CG, et al (2000) Breast adipose tissue concentrations of polychlorinated biphenyls and other organochlorines and breast cancer risk. Cancer Epidemiol Biomarkers Prev 9(1):55–63PubMedGoogle Scholar
  16. 16.
    Millikan R, DeVoto E, Duell EJ, et al (2000) Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev 9(11):1233–1240PubMedGoogle Scholar
  17. 17.
    van’t Veer P, Lobbezoo IE, Martin-Moreno JM, et al (1997) DDT (dicophane) and postmenopausal breast cancer in Europe: case–control study. BMJ 315(7100):81–85Google Scholar
  18. 18.
    Zheng T, Holford TR, Mayne ST, et al (2000) Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2′-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev 9(2):167–74PubMedGoogle Scholar
  19. 19.
    Woolcott CG, Aronson KJ, Hanna WM, et al (2001) Organochlorines and breast cancer risk by receptor status, tumor size, and grade (Canada). Cancer Causes Control 12(5):395–404PubMedCrossRefGoogle Scholar
  20. 20.
    Gammon MD, Wolff MS, Neugut AI, et al (2002) Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 11(8):686–697PubMedGoogle Scholar
  21. 21.
    Engel LS, Hill DA, Hoppin JA, et al (2005) Pesticide use and breast cancer risk among farmers’ wives in the agricultural health study. Am J Epidemiol 161(2):121–135PubMedCrossRefGoogle Scholar
  22. 22.
    Krieger N, Wolff MS, Hiatt RA, Rivera M, Vogelman J, Orentreich N (1994) Breast cancer and serum organochlorines: a prospective study among white, black, and Asian women. J Natl Cancer Inst 86(8):589–599PubMedGoogle Scholar
  23. 23.
    Laden F, Collman G, Iwamoto K, et al (2001) 1,1-Dichloro-2,2-bis( p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst 93(10):768–776PubMedCrossRefGoogle Scholar
  24. 24.
    Muscat JE, Britton JA, Djordjevic MV, et al (2003) Adipose concentrations of organochlorine compounds and breast cancer recurrence in Long Island, New York. Cancer Epidemiol Biomarkers Prev 12(12):1474–1478PubMedGoogle Scholar
  25. 25.
    Raaschou-Nielsen O, Pavuk M, Leblanc A, et al (2005) Adipose organochlorine concentrations and risk of breast cancer among postmenopausal Danish women. Cancer Epidemiol Biomarkers Prev 14(1):67–74PubMedGoogle Scholar
  26. 26.
    Hoyer AP, Gerdes AM, Jorgensen T, Rank F, Hartvig HB (2002) Organochlorines, p53 mutations in relation to breast cancer risk and survival. A Danish cohort-nested case–controls study. Breast Cancer Res Treat 71(1):59–65PubMedCrossRefGoogle Scholar
  27. 27.
    Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P (2000) Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 9(3):271–277PubMedGoogle Scholar
  28. 28.
    Wolff MS, Toniolo PG, Lee EW, Rivera M, Dubin N (1993) Blood levels of organochlorine residues and risk of breast cancer. J Natl Cancer Inst 85(8):648–652PubMedGoogle Scholar
  29. 29.
    Stehr-Green PA, Farrar JA, Burse VW, Royce WG, Wohlleb JC (1988) A survey of measured levels and dietary sources of selected organochlorine pesticide residues and metabolites in human sera from a rural population. Am J Public Health 78(7):828–830PubMedGoogle Scholar
  30. 30.
    Zheng T, Holford TR, Mayne ST, et al (1999) DDE and DDT in breast adipose tissue and risk of female breast cancer. Am J Epidemiol 150(5):453–458PubMedGoogle Scholar
  31. 31.
    Rogan WJ (1996) Pollutants in breast milk. Arch Pediatr Adolesc Med 150(9):981–990PubMedGoogle Scholar
  32. 32.
    Stehr-Green PA (1989) Demographic and seasonal influences on human serum pesticide residue levels. J Toxicol Environ Health 27(4):405–421PubMedCrossRefGoogle Scholar
  33. 33.
    Schildkraut JM, Demark-Wahnefried W, DeVoto E, Hughes C, Laseter JL, Newman B (1999) Environmental contaminants and body fat distribution. Cancer Epidemiol Biomarkers Prev 8(2):179–183PubMedGoogle Scholar
  34. 34.
    Marchbanks PA, McDonald JA, Wilson HG, et al (2002) The NICHD women’s contraceptive and reproductive experiences study: methods and operational results. Ann Epidemiol 12(4):213–221PubMedCrossRefGoogle Scholar
  35. 35.
    Waksberg J (1978) Sampling methods for random digit dialing. J Am Stat Assoc 73:40–46CrossRefGoogle Scholar
  36. 36.
    Norman SA, Berlin JA, Weber AL, et al (2003) Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women. Cancer Causes Control 14(10):933–943PubMedCrossRefGoogle Scholar
  37. 37.
    Longnecker MP, Bernstein L, Bird CL, Yancey AK, Peterson JC (1996) Measurement of organochlorine levels in postprandial serum or in blood collected in serum separator tubes. Cancer Epidemiol Biomarkers Prev 5(9):753–755PubMedGoogle Scholar
  38. 38.
    Sherma J (1980) Manual of analytical methods for the analysis of pesticides in humans and environmental samples. Health Effects Laboratory; Research Triangle Park, NCGoogle Scholar
  39. 39.
    Burse VW, Korver MP, Needham LL, et al (1989) Gas chromatographic determination of polychlorinated biphenyls (as Aroclor 1254) in serum: collaborative study. J Assoc Off Anal Chem 72(4):649–659Google Scholar
  40. 40.
    Webb RG, McCall AC (1973) Quantitative PCB standards for electron capture gas chromatography. J Chromatogr Sci 11(7):366–373PubMedGoogle Scholar
  41. 41.
    Erickson MD (1997) Analytical chemistry of PCBs. 2nd ed. Lewis, New YorkGoogle Scholar
  42. 42.
    Takayama M, Itoh S, Nagasaki T, Tanimizu I (1977) A new enzymatic method for determination of serum choline-containing phospholipids. Clin Chim Acta 79(1):93–98PubMedCrossRefGoogle Scholar
  43. 43.
    McGowan MW, Artiss JD, Strandbergh DR, Zak B (1983) A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29(3):538–542PubMedGoogle Scholar
  44. 44.
    Beckman Instruments I (1993) CS-7 Operations Manual. Beckman Instruments, Inc. Irvine, CAGoogle Scholar
  45. 45.
    Richmond W (1973) Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum. Clin Chem 19(12):1350–1356PubMedGoogle Scholar
  46. 46.
    Phillips DL, Pirkle JL, Burse VW, Bernert JT, Jr, Henderson LO, Needham LL (1989) Chlorinated hydrocarbon levels in human serum: effects of fasting and feeding. Arch Environ Contam Toxicol 18(4):495–500PubMedCrossRefGoogle Scholar
  47. 47.
    Press M (1993) Estrogen and progesterone receptors in breast cancer. Adv Pathol Lab Med 6:117–148Google Scholar
  48. 48.
    Wen WH, Reles A, Runnebaum IB, et al (1999) p53 mutations and expression in ovarian cancers: correlation with overall survival. Int J Gynecol Pathol 18(1):29–41PubMedGoogle Scholar
  49. 49.
    Lukas J, Niu N, Press MF (2000) p53 mutations and expression in breast carcinoma in situ. Am J Pathol 156(1):183–191PubMedGoogle Scholar
  50. 50.
    Saffari B, Bernstein L, Hong DC, et al (2005) Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas. Int J Gynecol Cancer 15(5):952–963PubMedCrossRefGoogle Scholar
  51. 51.
    Press MFSB, Groshen S, Kaminsky D, et al (2002) Monoclonal antibodies designed for immunohistochemical detection of progesterone receptor in archival breast cancer specimens. Steroids 67:799–813PubMedCrossRefGoogle Scholar
  52. 52.
    Press MF, Slamon DJ, Flom KJ, Park J, Zhou JY, Bernstein L (2002) Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Oncol 20(14):3095–105PubMedGoogle Scholar
  53. 53.
    Press MF, Sauter G, Bernstein L, et al (2005) Diagnostic evaluation of HER-2 as a molecular target: an assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials. Clin Cancer Res 11(18):6598–607PubMedCrossRefGoogle Scholar
  54. 54.
    Park JM, Yang X, Park JJ, Press OW, Press MF (1999) Assessment of novel anti-p185HER-2 monoclonal antibodies for internalization-dependent therapies. Hybridoma 18(6):487–495PubMedGoogle Scholar
  55. 55.
    Press M, Spaulding B, Groshen S, et al (2002) Comparison of different antibodies for detection of progesterone receptor in breast cancer. Steroids 67(9):799–813PubMedCrossRefGoogle Scholar
  56. 56.
    Bernstein L (2006) Control recruitment in population-based case–control studies. Epidemiology 17(3):255–257PubMedCrossRefGoogle Scholar
  57. 57.
    Coradini D, Daidone MG (2004) Biomolecular prognostic factors in breast cancer. Curr Opin Obstet Gynecol 16(1):49–55PubMedCrossRefGoogle Scholar
  58. 58.
    Mass RD (2004) The HER receptor family: a rich target for therapeutic development. Int J Radiat Oncol Biol Phys 58(3):932–940PubMedCrossRefGoogle Scholar
  59. 59.
    Sledge GW, Jr (2004) HERe-2 stay: the continuing importance of translational research in breast cancer. J Natl Cancer Inst 96(10):725–727PubMedCrossRefGoogle Scholar
  60. 60.
    Anderson E (2002) The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res 4(5):197–201PubMedCrossRefGoogle Scholar
  61. 61.
    Dickson RB, Stancel GM (2000) Estrogen receptor-mediated processes in normal and cancer cells. J Natl Cancer Inst Monogr 2000(27):135–145Google Scholar
  62. 62.
    Gammon MD, Wolff MS, Neugut AI, et al (1996) Treatment for breast cancer and blood levels of chlorinated hydrocarbons. Cancer Epidemiol Biomarkers Prev 5(6):467–471PubMedGoogle Scholar
  63. 63.
    Henderson BE, Feigelson HS (2000) Hormonal carcinogenesis. Carcinogenesis 21(3):427–433PubMedCrossRefGoogle Scholar
  64. 64.
    Rusiecki JA, Matthews A, Sturgeon S, et al (2005) A correlation study of organochlorine levels in serum, breast adipose tissue, and gluteal adipose tissue among breast cancer cases in India. Cancer Epidemiol Biomarkers Prev 14(5):1113–1124Google Scholar
  65. 65.
    Rogan WJ, Gladen BC, McKinney JD, et al (1986) Polychlorinated biphenyls (PCBs) and dichlorodiphenyl dichloroethene (DDE) in human milk: effects of maternal factors and previous lactation. Am J Public Health 76(2):172–177PubMedCrossRefGoogle Scholar
  66. 66.
    DeVoto E, Fiore BJ, Millikan R, et al (1997) Correlations among human blood levels of specific PCB congeners and implications for epidemiologic studies. Am J Ind Med 32(6):606–613PubMedCrossRefGoogle Scholar
  67. 67.
    Newcomb PA (1997) Lactation and breast cancer risk. J Mammary Gland Biol Neoplasia 2(3):311–318PubMedCrossRefGoogle Scholar
  68. 68.
    Kutz FW, Yobs AR, Strassman SC (1977) Racial stratification of organochlorine insecticide residues in human adipose tissue. J Occup Med 19(9):619–622PubMedGoogle Scholar
  69. 69.
    Bernstein L, Teal CR, Joslyn S, Wilson J (2003) Ethnicity-related variation in breast cancer risk factors. Cancer 97(1 Suppl):222–229PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2006

Authors and Affiliations

  • Nicole M. Gatto
    • 1
  • Matthew P. Longnecker
    • 2
  • Michael F. Press
    • 3
  • Jane Sullivan-Halley
    • 1
  • Roberta McKean-Cowdin
    • 1
  • Leslie Bernstein
    • 1
  1. 1.Department of Preventive MedicineKeck School of Medicine of the University of Southern California, USC/Norris Comprehensive CenterLos AngelesUSA
  2. 2.Department of Health and Human ServicesNational Institute of Environmental Health Sciences, National Institutes of HealthResearch Triangle ParkUSA
  3. 3.Department of PathologyKeck School of Medicine of the University of Southern CaliforniaLos AngelesUSA

Personalised recommendations